THE Therapeutic Goods
Administration has issued more
details of suspected adverse
reactions to Panvax,with a total of
1960 suspected side effects
reported as at 17 Sep - but only
190 related to Panvax Junior.
The TGA said it continues to
maintain that Panvax is a “safe,
effective vaccine for prevention of
the H1N1 influenza”.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Oct 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Oct 10
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.